Synovis Life Technologies, Inc. (NASDAQ: SYNO), reported strong revenue performance for the fourth fiscal quarter and full fiscal year ended Oct. 31, 2009. For the 2009 fiscal fourth quarter, net revenue rose to $15.0 million, an 18 percent increase over $12.7 million in the year-ago period. Net income on a GAAP basis for the fiscal [...]
Life's tag archives
Synovis Life Technologies Reports 18 Percent Revenue Growth for Fiscal 2009 Fourth Quarter
SeraCare Reports Fourth Quarter and Fiscal Year 2009 Results
SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, reported operational and financial results for its fourth quarter and fiscal year ended September 30, 2009. SeraCare delivered revenue of $12.5 million for the quarter ended September [...]
Continue reading " SeraCare Reports Fourth Quarter and Fiscal Year 2009 Results "
Synovis Life Technologies Reports Record Revenue of $15 Million for the Third Quarter of Fiscal 2009
Synovis Life Technologies, Inc. (NASDAQ: SYNO), reported record revenue for the third quarter ended July 31, 2009. For the 2009 fiscal third quarter, net revenue rose to $15.0 million, a 12 percent increase over $13.4 million in the year-ago period. Net loss on a GAAP basis for the third quarter of fiscal 2009 was $(4.9) [...]
Recent Articles
-
- Vertex Pharmaceuticals Reports Second Quarter 2010 Financial Results and Highlights Recent Business and Clinical Progress
- AMAG Pharmaceuticals Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2010
- CardioNet, Inc. Reports Second Quarter 2010 Financial Results
- NPS Pharmaceuticals to Report Second Quarter 2010 Financial Results
- BioAlliance Pharma SA: A Record Turnover for Q2 2010 Reflecting the Successful US FDA Approval
- HealthStream Announces Second Quarter 2010 Results
- Simulations Plus Reports Third Quarter FY2010 Financial Results
- ZOLL Medical Corporation to Announce Third Quarter Results
- AngioDynamics Reports Strong Finish to Fiscal 2010
- Cubist Pharmaceuticals 2Q10 Total Net Revenues Up 29% to $168.5 Million
- Furiex Pharmaceuticals Announces Second Quarter 2010 Earnings Release and Conference Call
- Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2010
- Biomet Announces Fourth Quarter and Fiscal Year 2010 Financial Results
- Allergan Announces Quarterly Conference Call
- Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2010










































